Form 4/A for RCEL AVITA Medical, Inc.
Accepted 2022-07-06 00:00:00 ET · period of report 2021-07-06 · accession 0001209191-22-041372 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2022-07-06 | 2021-07-06 | RCEL | Shiroma Donna | GC | A - Grant | — | +10.5K | 10.5K | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-06 | A | A | 10,500 | — | 10,500 | D | — | — | (F1) Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments upon the satisfaction of certain performance-based vesting criteria with respect to the particular portion of Restricted Stock Units. (F2) This Form 4/A is being filed solely to correct an administrative error in the number of shares of Common Stock shown as beneficially held by the Reporting Person in her Form 4 filed on September 7, 2021 (the "Original Form 4"). All other information set forth in the Original Form 4 remains correct. |